PRKAA1/PRKAA2 antibody (pThr172, pThr183)
Quick Overview for PRKAA1/PRKAA2 antibody (pThr172, pThr183) (ABIN7250794)
Target
Reactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- pThr172, pThr183
-
Characteristics
- Phosphorylated antibody
-
Purification
- Affinity purification
-
Immunogen
- Synthesized peptide derived from human AMPKalpha1/2 around the phosphorylation site of Thr183/172
-
Isotype
- IgG
-
-
-
-
Application Notes
- WB 1:500-1:2000, IHC 1:100-1:300, IF 1:50-1:200, ELISA 1:40000
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- PBS with 0.02 % sodium azide, 0.5 % BSA and 50 % glycerol, pH 7.4
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20°C. Avoid freeze / thaw cycles.
-
-
- PRKAA1/PRKAA2 (AMPK1/AMPK2)
-
Alternative Name
- AMPK alpha1/2
-
Background
- AMPK (for 5'-AMP-activated protein kinase) is a heterotrimeric complex comprising a catalytic α subunit and regulatory β and γ subunits. It protects cells from stresses that cause ATP depletion by switching off ATP-consuming biosynthetic pathways. AMPK is activated by high AMP and low ATP through a mechanism involving allosteric regulation, promotion of phosphorylation by an upstream protein kinase known as AMPK kinase, and inhibition of dephosphorylation.Activated AMPK can phosphorylate and regulate in vivo hydroxymethylglutaryl-CoA reductase and acetyl-CoA carboxylase, which are key regulatory enzymes of sterol synthesis and fatty acid synthesis, respectively.
-
Molecular Weight
-
Observed_MW: 63 kDa
Calculated_MW: 62 kDa
-
UniProt
- Q13131, P54646
Target
-